Ian F. Smith
2009
In 2009, Ian F. Smith earned a total compensation of $9.1M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 302% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $403,245 |
|---|---|
| Option Awards | $7,803,839 |
| Salary | $479,250 |
| Stock Awards | $405,297 |
| Other | $12,405 |
| Total | $9,104,036 |
Smith received $7.8M in option awards, accounting for 86% of the total pay in 2009.
Smith also received $403.2K in non-equity incentive plan, $479.3K in salary, $405.3K in stock awards and $12.4K in other compensation.
Rankings
In 2009, Ian F. Smith's compensation ranked 266th out of 9,885 executives tracked by ExecPay. In other words, Smith earned more than 97.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 266 out of 9,885 | 97th |
Division Manufacturing | 90 out of 3,690 | 98th |
Major group Chemicals And Allied Products | 25 out of 866 | 97th |
Industry group Drugs | 22 out of 638 | 97th |
Industry Pharmaceutical Preparations | 20 out of 446 | 96th |
Source: SEC filing on April 10, 2012.
Smith's colleagues
We found six more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2009.
2009
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2009
Nancy Wysenski
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2009
Joshua Boger
Vertex Pharmaceuticals
Chief Executive Officer
2009
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2009
Amit Sachdev
Vertex Pharmaceuticals
Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada
2009
Kenneth Boger
Vertex Pharmaceuticals